Hello Subscribers!
Let the good times roll!
September was an incredibly strong month for biopharma stocks. The XBI is over $100, and biotech is back in favor. Nothing will ever go wrong again! 😳
In this week’s podcast, I provide my thoughts on LRMR, what went wrong with MLTX, and serve up two new ideas - one short-term and one long-term.
I’m also providing some slides below for your enhanced listening pleasure!
Cheers,
JNap
Listen to this episode with a 7-day free trial
Subscribe to JNap’s Substack to listen to this post and get 7 days of free access to the full post archives.
